Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Cash (2023 - 2025)

Historic Change in Cash for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $55.4 million.

  • Fractyl Health's Change in Cash rose 40605.86% to $55.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year decrease of 11758.39%. This contributed to the annual value of $33.9 million for FY2024, which is 31556.05% up from last year.
  • As of Q3 2025, Fractyl Health's Change in Cash stood at $55.4 million, which was up 40605.86% from -$19.8 million recorded in Q2 2025.
  • Fractyl Health's Change in Cash's 5-year high stood at $88.2 million during Q1 2024, with a 5-year trough of -$25.4 million in Q1 2025.
  • Moreover, its 3-year median value for Change in Cash was -$11.7 million (2023), whereas its average is $2.6 million.
  • The largest annual percentage gain for Fractyl Health's Change in Cash in the last 5 years was 102177.18% (2024), contrasted with its biggest fall of 20767.22% (2024).
  • Fractyl Health's Change in Cash (Quarter) stood at -$11.3 million in 2023, then plummeted by 52.33% to -$17.2 million in 2024, then surged by 421.9% to $55.4 million in 2025.
  • Its Change in Cash was $55.4 million in Q3 2025, compared to -$19.8 million in Q2 2025 and -$25.4 million in Q1 2025.